Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifecare AS ( (DE:LFC0) ) has shared an update.
Lifecare ASA reports that the Norwegian Press Complaints Commission has upheld its complaint against Finansavisen’s 2025 coverage of the company’s stock exchange announcements, finding breaches of good press practice including blurred lines between fact and opinion, unsupported headlines, and inadequate correction of errors. Following the same media coverage, the Norwegian Financial Supervisory Authority reviewed Lifecare’s market communication around its long-term wireless glucose monitoring study, but closed the case without further action, which the company interprets as confirmation that its announcements were a legitimate information source for the market; Lifecare argues the episode underscores how unethical financial reporting can distort share prices and disproportionately harm small shareholders, while reinforcing the need for accurate, clearly differentiated news and commentary to maintain confidence in both media and capital markets.
More about Lifecare AS
Lifecare ASA is a Norwegian medical sensor company focused on developing next-generation continuous glucose monitoring (CGM) systems using osmotic pressure as a sensing principle. Its sensor technology is designed for sensing and monitoring various analytes and molecules in the human body and in pets, with a primary market focus on wireless glucose monitoring solutions.
Average Trading Volume: 673,447
Current Market Cap: NOK138M
For a thorough assessment of LFC0 stock, go to TipRanks’ Stock Analysis page.